These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22801507)

  • 1. HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells.
    Tierney BJ; McCann GA; Cohn DE; Eisenhauer E; Sudhakar M; Kuppusamy P; Hideg K; Selvendiran K
    Cancer Biol Ther; 2012 Jul; 13(9):766-75. PubMed ID: 22801507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
    Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
    Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer Cells.
    Mast JM; Tse D; Shee K; Lakshmi Kuppusamy M; Kmiec MM; Kálai T; Kuppusamy P
    Cell Biochem Biophys; 2019 Jun; 77(2):109-119. PubMed ID: 31089934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma.
    Bixel K; Saini U; Kumar Bid H; Fowler J; Riley M; Wanner R; Deepa Priya Dorayappan K; Rajendran S; Konishi I; Matsumura N; Cohn DE; Selvendiran K
    Int J Cancer; 2017 Nov; 141(9):1856-1866. PubMed ID: 28646535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer.
    Rath KS; Naidu SK; Lata P; Bid HK; Rivera BK; McCann GA; Tierney BJ; Elnaggar AC; Bravo V; Leone G; Houghton P; Hideg K; Kuppusamy P; Cohn DE; Selvendiran K
    Cancer Res; 2014 Apr; 74(8):2316-27. PubMed ID: 24590057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.
    Whicker ME; Lin ZP; Hanna R; Sartorelli AC; Ratner ES
    BMC Cancer; 2016 Jul; 16():550. PubMed ID: 27465688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT116 cells.
    Park KW; Kundu J; Chae IG; Kim DH; Yu MH; Kundu JK; Chun KS
    Int J Oncol; 2014 Apr; 44(4):1309-15. PubMed ID: 24481553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer.
    ElNaggar AC; Saini U; Naidu S; Wanner R; Sudhakar M; Fowler J; Nagane M; Kuppusamy P; Cohn DE; Selvendiran K
    Cancer Biol Ther; 2016 Oct; 17(10):1107-1115. PubMed ID: 27415751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.
    Pulliam N; Fang F; Ozes AR; Tang J; Adewuyi A; Keer H; Lyons J; Baylin SB; Matei D; Nakshatri H; Rassool FV; Miller KD; Nephew KP
    Clin Cancer Res; 2018 Jul; 24(13):3163-3175. PubMed ID: 29615458
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells.
    Hu Y; Zhao C; Zheng H; Lu K; Shi D; Liu Z; Dai X; Zhang Y; Zhang X; Hu W; Liang G
    Anticancer Drugs; 2017 Apr; 28(4):392-400. PubMed ID: 28067673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs.
    Butturini E; Carcereri de Prati A; Chiavegato G; Rigo A; Cavalieri E; Darra E; Mariotto S
    Free Radic Biol Med; 2013 Dec; 65():1322-1330. PubMed ID: 24095958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
    Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
    Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
    Chock KL; Allison JM; Shimizu Y; ElShamy WM
    Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status.
    Gadducci A; Guarneri V; Peccatori FA; Ronzino G; Scandurra G; Zamagni C; Zola P; Salutari V
    J Ovarian Res; 2019 Jan; 12(1):9. PubMed ID: 30691488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
    Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
    Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rucaparib: a novel PARP inhibitor for
    Colombo I; Lheureux S; Oza AM
    Drug Des Devel Ther; 2018; 12():605-617. PubMed ID: 29606854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active Hexose Correlated Compound (AHCC) Inhibits the Proliferation of Ovarian Cancer Cells by Suppressing Signal Transducer and Activator of Transcription 3 (STAT3) Activation.
    Choi JY; Lee S; Yun SM; Suh DH; Kim K; No JH; Jeong EH; Kim YB
    Nutr Cancer; 2018 Jan; 70(1):109-115. PubMed ID: 29111786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.
    Sampson VB; Vetter NS; Kamara DF; Collier AB; Gresh RC; Kolb EA
    PLoS One; 2015; 10(11):e0142704. PubMed ID: 26571493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells.
    Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Tazi M; Bratasz A; Tong L; Rivera BK; Kálai T; Hideg K; Kuppusamy P
    Free Radic Biol Med; 2010 May; 48(9):1228-35. PubMed ID: 20156552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.